Clinical Trial Update: Role of Carnosine as an Adjuvant Therapy for Diabetic Nephropathy in Pediatrics With Type 1 Diabetes [NA]

View source ↗

Summary

This clinical trial update notes the completion of a study evaluating carnosine as adjuvant therapy for diabetic nephropathy in children with Type 1 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy
• Type 1 Diabetes Mellitus

Drugs mentioned

• Carnosine (carnosine)

Snippet

Sponsor: Ain Shams University | Conditions: Type 1 Diabetes, Oxidative Stress | NA | Status: COMPLETED